Detalhe da pesquisa
1.
Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab.
Biomed Rep
; 17(3): 76, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950098